Why Biopharma Operating Models Collapse Under Scale: What regulatory operations and R&D platforms reveal about how organizations actually function. The Fireside Chat with Frits Stulp from at the Implement Consulting Group's Veeva Consortium in November 2025.
Most life sciences organizations don’t struggle because of regulation—they struggle because of how they interpret it.
From the vantage point of Global Regulatory and R&D information systems, this episode examines why modern platforms like Veeva promise leverage but often deliver friction. The issue isn’t technology—it’s how operating models distribute ownership across IT, Quality, and the business, and how risk is interpreted at scale.
This conversation explores how over-validation, misaligned incentives, and legacy thinking slow execution, fragment systems of record, and ultimately increase risk.
This is not a technology discussion.
It is a systems-level diagnosis.
This episode is based on a fireside chat with Fritz Stolp at an industry session hosted by Implement Consulting Group, exploring real-world experiences with Veeva Systems platforms in regulatory and R&D environments.
Key Themes
1. The Expectation Gap
Organizations expect a connected operating system but configure fragmented tools.
Platforms designed to unify data and workflows become siloed and underutilized.
2. Misaligned Ownership Across Functions
Result: No single group owns the outcome.
3. Over-Validation as Risk Creation
Validation is necessary—but often misapplied.
When simple changes take weeks or months:
Risk doesn’t go away. It moves.
4. Decision Latency at Scale
Governance structures intended to reduce risk often increase it by slowing execution and diffusing accountability.
Simple configuration changes become prolonged processes, creating friction across the organization.
5. SaaS Reality vs Legacy Thinking
Modern platforms evolve continuously.
Organizations that resist change fall behind the very capabilities designed to improve them.
In no other industry do customers ask technology providers to stop innovating.
6. The User Adaptability Myth
A major interface change introduced no disruption in practice.
Users adapt quickly.
Organizations assume they won’t.
This gap reinforces unnecessary controls and slows adoption.
7. Trust as an Operating Requirement
Execution speed depends on trust:
Reducing redundant validation and enabling faster deployment requires explicit risk ownership.
8. Patient Time as the Ultimate Constraint
Operational delay is not abstract.
In some cases, time spent in internal processes directly impacts patient outcomes.
Efficiency is not just a business concern—it is an ethical obligation.
Key Quotes
“Most organizations don’t fail because of technology—they fail because no one owns how it’s supposed to work.”
“Over-validation doesn’t reduce risk—it pushes work out of the system of record.”
“If a simple change takes months, the system has already failed.”
“We don’t need less regulation—we need better interpretation.”
Who Should Listen
What This Episode Is Not
This is a diagnosis of how operating models behave under scale and constraint.
Closing Thought
Regulatory operations don’t just execute the operating model. They expose it.
Information Mentioned in this Episode:
Summaries and show notes created from transcript using ChatGPT w/ some light editing - let me know if you find anything crazy that needs to change.